Jackson Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Jackson Wealth Management's GILD Position: Q3 2025 in Review
Jackson Wealth Management sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 4,747 shares — an estimated $526K sold.
Jackson Wealth Management first reported a position in GILD in Q4 2014 and held it in 13 quarters. The position peaked at $2.25M in Q2 2015. 2,033 funds tracked by Wall St. Rank hold GILD as of Q3 2025.
- Jackson Wealth Management reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
- Jackson Wealth Management sold 4,747 Gilead Sciences shares in Q3 2025, an estimated $526K.
- Jackson Wealth Management first reported a position in Gilead Sciences in Q4 2014 and held it in 13 quarters.
- Jackson Wealth Management's Gilead Sciences position peaked at $2.25M in Q2 2015.
- 2,033 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.
Based on Jackson Wealth Management's 13F filing for Q3 2025, filed 3 Oct 2025.